Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, View ORCID ProfileAhmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
doi: https://doi.org/10.1101/2021.11.20.21266229
Hossein Faramarzi
1Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
M.D.Amirhossein Sahebkar
2Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran E-mail address:
3Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Pharm.D., Ph.D.Ahmad Hosseinpour
4Shimi Teb Salamat Co., Shiraz, Iran. E-mail address:
M.Sc.Vahid Khaloo
5Ali Asghar Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
M.D.Parisa Chamanpara
6Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Ph.D.Mohammad Reza Heydari
7Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Pharm.D., Ph.D.Sajad Najafi
8Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. E-mail address:
Ph.D.Fatemeh Fotoohi Khankahdany
4Shimi Teb Salamat Co., Shiraz, Iran. E-mail address:
M.Sc.Ahmad Movahedpour
9Behbahan Faculty of Medical Sciences, Behbahan, Iran. E-mail address:
Ph.D.Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted November 25, 2021.
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4684)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2980)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4472)
- Nursing (239)
- Nutrition (656)
- Oncology (2322)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1212)
- Primary Care Research (509)
- Public and Global Health (7060)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (448)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)